Assessment of Factors That Affected Respiratory Parameters in Mucopolysaccharidoses Patients

NCT ID: NCT04491747

Last Updated: 2020-07-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-01

Study Completion Date

2020-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Respiratory system affects in mucopolysaccharidosis (MPS) disease. Respiratory system symptoms are seen in almost every MPS patients and respiratory failure is one of the most common causes of death in this population. The aim of the study was to evaluate respiratory muscle strength and endurance, cough effectiveness and functional capacity in MPS patients and to defined the factors that affected the respiratory problem in this.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study was participated MPS patients. Patients' pulmonary function test, functional capacity, respiratory muscle strength and endurance, peak cough flow was assessed and recorded.

Pulmonary function test was assessed with spirometry, functional capacity was evaluated with 3-minute step test and six minute walk test (MWT). Respiratory muscle strength was evaluated mouth pressure measurement (MIP- maximal inspiratory pressure and MEP- maximal expiratory pressure) and Sniff nasal inspiratory pressure (SNIP). Respiratory muscle endurance was assessed Powerbreathe. And cough effectiveness was evaluated peak cough flow.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mucopolysaccharidoses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

functional capacity

Six minute walk test used assessment of functional capacity.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Exercise capacity

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People who diagnosed Mucopolysaccharidoses disease in Hacettepe University.
* Cooperation

Exclusion Criteria

* Patients who were not walking ability.
Minimum Eligible Age

7 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hacettepe University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kübra Kılıç

Physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Deniz Dogru- Ersoz, Professor

Role: STUDY_DIRECTOR

Hacettepe University

Naciye Vardar- Yagli, PhD

Role: STUDY_CHAIR

Hacettepe University

Dilber Ademhan- Tural, MD

Role: STUDY_CHAIR

Hacettepe University

Nural Kiper, Professor

Role: STUDY_CHAIR

Hacettepe University

Ugur Ozcelik, Professor

Role: STUDY_CHAIR

Hacettepe University

Ebru Yalcin, Professor

Role: STUDY_CHAIR

Hacettepe University

Deniz Inal-Ince, Professor

Role: STUDY_CHAIR

Hacettepe University

Melda Saglam, PhD

Role: STUDY_CHAIR

Hacettepe University

Serap Sivri, Professor

Role: STUDY_CHAIR

Hacettepe University

Aysegul Tokatlı, Professor

Role: STUDY_CHAIR

Hacettepe University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hacettepe University

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GO 19/97

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.